Journal of Human Reproductive Sciences

REVIEW ARTICLE
Year
: 2015  |  Volume : 8  |  Issue : 1  |  Page : 3--13

Fertility preservation in female cancer patients: An overview


Nalini Mahajan 
 Department of Reproductive Medicine, Nova IVI Fertilit, New Delhi, India

Correspondence Address:
Nalini Mahajan
Department of Reproductive Medicine, Nova IVI Fertility, B 2/1A Safdarjang Enclave, Africa Avenue, New Delhi - 110 029
India

Fertility preservation is becoming increasingly important to improve the quality of life in cancer survivors. Despite guidelines suggesting that discussion of fertility preservation should be done prior to starting cancer therapies, there is a lack of implementation in this area. A number of techniques are available for fertility preservation, and they can be used individually or together in the same patient to maximize efficiency. Oocyte and embryo cryopreservation are now established techniques but have their limitations. Ovarian tissue cryopreservation though considered experimental at present, has a wider clinical application and the advantage of keeping the fertility window open for a longer time. Both chemotherapy and radiotherapy have a major impact on reproductive potential and fertility preservation procedures should be carried out prior to these treatments. The need for fertility preservation has to be weighed against morbidity and mortality associated with cancer. There is thus a need for a multidisciplinary collaboration between oncologists and reproductive specialists to improve awareness and availability.


How to cite this article:
Mahajan N. Fertility preservation in female cancer patients: An overview.J Hum Reprod Sci 2015;8:3-13


How to cite this URL:
Mahajan N. Fertility preservation in female cancer patients: An overview. J Hum Reprod Sci [serial online] 2015 [cited 2021 Mar 1 ];8:3-13
Available from: https://www.jhrsonline.org/article.asp?issn=0974-1208;year=2015;volume=8;issue=1;spage=3;epage=13;aulast=Mahajan;type=0